Ys Biopharma Co Ltd Stock Forecast, Predictions & Price Target

Analyst price target for YS

Based on 1 analyst offering 12 month price targets for Ys Biopharma Co Ltd.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell YS stock?

Based on 1 analyst offering ratings for Ys Biopharma Co Ltd.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their YS stock forecasts and price targets.

YS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color

1 of 1

YS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CGEN$0.65$8.50+1,217.83%Strong Buy
SLDB$2.82$5.00+77.30%Strong Buy
CKPT$2.41$27.25+1,030.71%Strong Buy

Ys Biopharma Co Stock Forecast FAQ

Is Ys Biopharma Co Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: YS) stock is to Buy YS stock.

Out of 1 analyst, 0 (0%) are recommending YS as a Strong Buy, 1 (100%) are recommending YS as a Buy, 0 (0%) are recommending YS as a Hold, 0 (0%) are recommending YS as a Sell, and 0 (0%) are recommending YS as a Strong Sell.

If you're new to stock investing, here's how to buy Ys Biopharma Co stock.

What is YS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year YS price target, the average YS price target is $5.25, with the highest YS stock price forecast at $5.25 and the lowest YS stock price forecast at $5.25.

The Wall Street analyst predicted that Ys Biopharma Co's share price could reach $5.25 by Nov 13, 2024. The average Ys Biopharma Co stock price prediction forecasts a potential upside of 756.44% from the current YS share price of $0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.